Pacific Biosciences Of California Current Ratio 2010-2025 | PACB
Pacific Biosciences Of California current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Pacific Biosciences Of California Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.45B | $0.07B | 6.68 |
| 2024-12-31 | $0.50B | $0.07B | 7.48 |
| 2024-09-30 | $0.58B | $0.06B | 9.74 |
| 2024-06-30 | $0.63B | $0.08B | 8.01 |
| 2024-03-31 | $0.68B | $0.07B | 9.28 |
| 2023-12-31 | $0.74B | $0.10B | 7.81 |
| 2023-09-30 | $0.88B | $0.18B | 4.80 |
| 2023-06-30 | $0.94B | $0.27B | 3.45 |
| 2023-03-31 | $0.98B | $0.27B | 3.69 |
| 2022-12-31 | $0.85B | $0.26B | 3.24 |
| 2022-09-30 | $0.91B | $0.08B | 11.19 |
| 2022-06-30 | $0.97B | $0.08B | 11.50 |
| 2022-03-31 | $1.03B | $0.06B | 16.87 |
| 2021-12-31 | $1.10B | $0.07B | 15.36 |
| 2021-09-30 | $1.13B | $0.06B | 20.32 |
| 2021-06-30 | $1.19B | $0.05B | 26.17 |
| 2021-03-31 | $1.20B | $0.03B | 35.45 |
| 2020-12-31 | $0.36B | $0.04B | 9.24 |
| 2020-09-30 | $0.24B | $0.13B | 1.84 |
| 2020-06-30 | $0.15B | $0.13B | 1.15 |
| 2020-03-31 | $0.17B | $0.13B | 1.29 |
| 2019-12-31 | $0.08B | $0.05B | 1.65 |
| 2019-09-30 | $0.08B | $0.05B | 1.52 |
| 2019-06-30 | $0.10B | $0.05B | 2.00 |
| 2019-03-31 | $0.11B | $0.05B | 2.50 |
| 2018-12-31 | $0.13B | $0.03B | 4.90 |
| 2018-09-30 | $0.14B | $0.02B | 6.65 |
| 2018-06-30 | $0.10B | $0.02B | 4.33 |
| 2018-03-31 | $0.12B | $0.03B | 4.64 |
| 2017-12-31 | $0.10B | $0.03B | 3.55 |
| 2017-09-30 | $0.11B | $0.03B | 3.75 |
| 2017-06-30 | $0.13B | $0.04B | 3.72 |
| 2017-03-31 | $0.09B | $0.04B | 2.49 |
| 2016-12-31 | $0.11B | $0.03B | 3.23 |
| 2016-09-30 | $0.12B | $0.03B | 3.81 |
| 2016-06-30 | $0.14B | $0.03B | 4.08 |
| 2016-03-31 | $0.12B | $0.03B | 3.72 |
| 2015-12-31 | $0.11B | $0.04B | 2.90 |
| 2015-09-30 | $0.09B | $0.04B | 2.22 |
| 2015-06-30 | $0.09B | $0.04B | 2.31 |
| 2015-03-31 | $0.10B | $0.04B | 2.59 |
| 2014-12-31 | $0.12B | $0.03B | 3.74 |
| 2014-09-30 | $0.11B | $0.03B | 3.92 |
| 2014-06-30 | $0.12B | $0.03B | 4.29 |
| 2014-03-31 | $0.13B | $0.02B | 5.87 |
| 2013-12-31 | $0.13B | $0.02B | 5.61 |
| 2013-09-30 | $0.14B | $0.02B | 6.31 |
| 2013-06-30 | $0.12B | $0.02B | 8.09 |
| 2013-03-31 | $0.13B | $0.01B | 9.31 |
| 2012-12-31 | $0.12B | $0.02B | 7.80 |
| 2012-09-30 | $0.13B | $0.01B | 9.71 |
| 2012-06-30 | $0.15B | $0.02B | 10.23 |
| 2012-03-31 | $0.18B | $0.02B | 8.93 |
| 2011-12-31 | $0.20B | $0.02B | 10.30 |
| 2011-09-30 | $0.22B | $0.02B | 10.42 |
| 2011-06-30 | $0.25B | $0.02B | 11.40 |
| 2011-03-31 | $0.26B | $0.02B | 10.95 |
| 2010-12-31 | $0.29B | $0.02B | 14.07 |
| 2010-09-30 | $0.12B | $0.02B | 5.12 |
| 2010-06-30 | $0.00B | 0.00 | |
| 2010-03-31 | $0.00B | 0.00 | |
| 2009-12-31 | $0.00B | 0.00 | |
| 2009-09-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.381B | $0.154B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $182.564B | 79.96 |
| Thermo Fisher Scientific (TMO) | United States | $150.197B | 18.17 |
| Edwards Lifesciences (EW) | United States | $43.309B | 28.40 |
| IDEXX Laboratories (IDXX) | United States | $42.135B | 48.42 |
| Alcon (ALC) | Switzerland | $42.123B | 28.47 |
| DexCom (DXCM) | United States | $31.369B | 48.49 |
| IQVIA Holdings (IQV) | United States | $26.768B | 14.99 |
| Mettler-Toledo (MTD) | United States | $23.982B | 28.52 |
| STERIS (STE) | Ireland | $23.183B | 25.53 |
| Waters (WAT) | United States | $20.390B | 28.77 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.638B | 0.00 |
| Hologic (HOLX) | United States | $14.369B | 15.61 |
| Sysmex ADR (SSMXY) | Japan | $10.550B | 29.93 |
| Penumbra (PEN) | United States | $9.948B | 78.08 |
| Masimo (MASI) | United States | $8.956B | 33.04 |
| Globus Medical (GMED) | United States | $7.834B | 18.67 |
| Glaukos (GKOS) | United States | $5.723B | 0.00 |
| Teleflex (TFX) | United States | $5.228B | 8.63 |
| TransMedics (TMDX) | United States | $4.179B | 90.85 |
| Integer Holdings (ITGR) | United States | $4.110B | 21.54 |
| PROCEPT BioRobotics (PRCT) | United States | $3.332B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.481B | 14.78 |
| Nihon Kohden (NHNKY) | Japan | $2.265B | 25.98 |
| Veracyte (VCYT) | United States | $2.067B | 29.00 |
| Elekta AB (EKTAY) | Sweden | $1.901B | 17.09 |
| Alphatec Holdings (ATEC) | United States | $1.599B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.292B | 121.00 |
| Pulse Biosciences (PLSE) | United States | $1.029B | 0.00 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.901B | 4.79 |
| Beta Bionics (BBNX) | United States | $0.776B | 0.00 |
| IRadimed (IRMD) | United States | $0.741B | 37.57 |
| SiBone (SIBN) | United States | $0.698B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.561B | 8.73 |
| RxSight (RXST) | United States | $0.553B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.523B | 12.25 |
| OrthoPediatrics (KIDS) | United States | $0.493B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.482B | 0.00 |
| AxoGen (AXGN) | United States | $0.443B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.407B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.405B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.403B | 10.72 |
| Treace Medical Concepts (TMCI) | United States | $0.347B | 0.00 |
| NeuroPace (NPCE) | United States | $0.341B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| 908 Devices (MASS) | United States | $0.263B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.04 |
| Neuronetics (STIM) | United States | $0.228B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.210B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.204B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.153B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.147B | 0.00 |
| LENSAR (LNSR) | United States | $0.146B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.146B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Accuray (ARAY) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.100B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.088B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.30 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.071B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.063B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.043B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.32 |